Category: Latest News
-
Iridium shares edge higher despite second-quarter earnings miss (NASDAQ:IRDM)
Revenue beats expectations as acquisition costs weigh on profit Iridium Communications Inc. (NASDAQ:IRDM) reported second-quarter 2026 results on Wednesday that topped revenue expectations but fell short on earnings, as costs related to its pending acquisition by Rocket Lab weighed on profitability. The satellite communications company posted adjusted earnings per share of $0.09, below the analyst…
-
Old National Bancorp shares climb after second-quarter earnings exceed forecasts (NASDAQ:ONB)
Record quarterly profit tops Wall Street expectations Old National Bancorp (NASDAQ:ONB) reported stronger-than-expected second-quarter 2026 results on Wednesday, driven by higher revenue, solid loan growth and record profitability. The bank posted adjusted earnings per share of $0.65, ahead of the analyst consensus estimate of $0.63. Revenue on a fully taxable equivalent basis totaled $740.06 million,…
-
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS)
New lymphoma results support development programme Curis, Inc. (NASDAQ:CRIS) shares climbed 11% on Wednesday after the biotechnology company released encouraging updated clinical data for emavusertib in patients with Primary CNS Lymphoma (PCNSL) and raised enrollment expectations for its Chronic Lymphocytic Leukemia (CLL) study. Updated findings from the TakeAim Lymphoma trial showed an overall response rate…
-
Summit Therapeutics shares advance after updated Phase III cancer trial results (NASDAQ:SMMT)
New survival data supports ivonescimab treatment Summit Therapeutics Inc. (NASDAQ:SMMT) shares gained 3% on Wednesday after the company released updated overall survival data from its global Phase III HARMONi trial evaluating ivonescimab in combination with chemotherapy for advanced lung cancer. The study enrolled patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer…
-
Arrowhead Pharmaceuticals shares surge after positive Phase 3 results for plozasiran (NASDAQ:ARWR)
Late-stage studies achieve all primary and secondary goals Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) shares jumped 18% on Wednesday after the company announced positive topline data from its Phase 3 SHASTA-3 and SHASTA-4 clinical trials evaluating plozasiran in patients with severe hypertriglyceridemia. Both studies successfully met their primary endpoint of reducing triglyceride levels compared with placebo, while…
-
Oatly shares surge after second-quarter revenue beats forecasts and outlook improves (NASDAQ:OTLY)
Strong sales growth drives earnings outperformance Oatly Group AB (NASDAQ:OTLY) reported stronger-than-expected second-quarter 2026 results on Wednesday, with robust revenue growth prompting the company to raise its full-year sales outlook. The oat-based beverage maker generated revenue of $240.1 million during the quarter, a 15% increase from a year earlier and well above analysts’ consensus estimate…
-
Northern Trust shares edge higher after strong second-quarter results driven by Visa gain (NASDAQ:NTRS)
Earnings and revenue surpass Wall Street expectations Northern Trust Corporation (NASDAQ:NTRS) reported second-quarter 2026 results that comfortably exceeded analyst forecasts, supported by higher fee income and a significant gain related to its participation in Visa’s exchange offer. The company posted adjusted earnings per share of $4.23, well above the consensus estimate of $2.70. Revenue rose…
-
Joby Aviation shares climb on exclusive UK air taxi partnership with Virgin Atlantic (NYSE:JOBY)
Virgin Atlantic to become exclusive UK airline partner Joby Aviation (NYSE:JOBY) shares gained 4% on Wednesday after the electric aircraft developer announced a long-term partnership with Virgin Atlantic to introduce commercial air taxi services across the United Kingdom. The agreement, unveiled during the Farnborough International Airshow, names Virgin Atlantic as Joby’s exclusive airline partner for…
-
Powering Canada’s data centre future
Canada is rapidly emerging as a key destination for data centre development as artificial intelligence, cloud computing and digital transformation fuel unprecedented demand for digital infrastructure. Yet while much of the attention is focused on the facilities themselves, a critical challenge remains: securing reliable, scalable and cost-effective power to support increasingly energy-intensive workloads. This article…
-
AT&T shares rise after second-quarter earnings beat and stronger subscriber growth (NYSE:T)
Earnings outperform as customer additions gather pace AT&T (NYSE:T) shares climbed 2.5% in premarket trading on Wednesday after the telecommunications company reported second-quarter results that exceeded earnings expectations, supported by continued momentum in broadband and wireless customer growth. The company posted earnings per share of $0.65, ahead of analysts’ consensus estimate of $0.59. Quarterly revenue…